QUIDELORTHO CORP Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
QUIDELORTHO CORP (QDEL) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 300.00 thousand shares for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- QUIDELORTHO CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-28 was 300.00K shares, a 50.00% increase year-over-year.
- QUIDELORTHO CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-29 was 300.00K shares, a 25.00% decline year-over-year.
- QUIDELORTHO CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-28 was 100.00K shares, a 50.00% decline year-over-year.
- QUIDELORTHO CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-29 was 200.00K shares, a 0.00% change year-over-year.
- QUIDELORTHO CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 200.00K shares, a 0.00% change from fiscal 2024.
- QUIDELORTHO CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 200.00K shares, a 60.00% decline from fiscal 2023.
- QUIDELORTHO CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 500.00K shares, a 66.67% decline from fiscal 2023.
- QUIDELORTHO CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.50M shares, a 650.00% increase from fiscal 2022.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-28 | 300.00K shares 10-Q · filed 2026-08-07 | 300.00K shares 10-Q · filed 2026-08-07 | ||
| 2026-03-29 | 300.00K shares 10-Q · filed 2026-05-06 | |||
| 2025-12-28 | 200.00K shares 10-K · filed 2026-02-19 | |||
| 2025-09-28 | 100.00K shares 10-Q · filed 2025-11-06 | 300.00K shares 10-Q · filed 2025-11-06 | ||
| 2025-06-29 | 200.00K shares 10-Q · filed 2026-08-07 | 300.00K shares 10-Q · filed 2026-08-07 | ||
| 2025-03-30 | 400.00K shares 10-Q · filed 2026-05-06 | |||
| 2024-12-29 | 200.00K shares 10-K · filed 2026-02-19 | |||
| 2024-09-29 | 200.00K shares 10-Q · filed 2025-11-06 | 300.00K shares 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | 200.00K shares 10-Q · filed 2025-08-06 | 300.00K shares 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | 400.00K shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 500.00K shares 10-K · filed 2026-02-19 | |||
| 2023-10-01 | 400.00K shares 10-Q · filed 2024-11-08 | 500.00K shares 10-Q · filed 2024-11-08 | ||
| 2023-07-02 | 400.00K shares 10-Q · filed 2024-08-01 | 500.00K shares 10-Q · filed 2024-08-01 | ||
| 2023-04-02 | 1.50M shares 10-Q · filed 2023-05-04 | |||
| 2023-01-01 | 1.50M shares 10-K · filed 2023-02-23 | |||
| 2022-10-02 | 1.60M shares 10-Q · filed 2022-11-04 | 1.50M shares 10-Q · filed 2022-11-04 | ||
| 2022-07-03 | 1.30M shares 10-Q · filed 2022-08-05 | |||
| 2022-04-03 | 400.00K shares 10-Q · filed 2023-05-04 | |||
| 2022-01-02 | 200.00K shares 10-K · filed 2023-02-23 | |||
| 2021-10-03 | 200.00K shares 10-Q · filed 2022-11-04 | 100.00K shares 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | 100.00K shares 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | 0.00 shares 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |